Literature DB >> 21233964

Fecal occult blood screening for colorectal cancer.

W C Macdonald.   

Abstract

Fecal occult blood testing with guaiac gum is a simple, safe, and cheap method for screening for colorectal cancer. In the office setting, compliance is good. Asymptomatic colorectal cancers are detected at a more favourable pathologic stage than those detected in symptomatic patients. Because of the low positive predictive value of the test, many persons testing positive undergo unnecessary bowel examinations. As yet, randomized controlled studies have not shown that fecal occult blood screening reduces mortality from colorectal cancer. At present, screening with this test is left to the judgement of the individual physician.

Entities:  

Year:  1990        PMID: 21233964      PMCID: PMC2280450     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  9 in total

Review 1.  US Preventive Services Task Force. Sigmoidoscopy in the periodic health examination of asymptomatic adults.

Authors:  J V Selby; G D Friedman
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

2.  Diagnosis of large-bowel cancer in the asymptomatic patient.

Authors:  D H Greegor
Journal:  JAMA       Date:  1967-09-18       Impact factor: 56.272

3.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

4.  Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study.

Authors:  J S Mandel; J H Bond; M Bradley; D C Snover; T R Church; S Williams; G Watt; L M Schuman; F Ederer; V Gilbertsen
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

5.  Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects.

Authors:  J Kewenter; S Björk; E Haglind; L Smith; J Svanvik; C Ahrén
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

6.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.

Authors:  O Kronborg; C Fenger; J Olsen; K Bech; O Søndergaard
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

7.  Patient compliance with screening for fecal occult blood in family practice.

Authors:  P E Hoogewerf; T G Hislop; B J Morrison; S D Burns; R Sizto
Journal:  CMAJ       Date:  1987-08-01       Impact factor: 8.262

Review 8.  Detection and surveillance of colorectal cancer.

Authors:  D E Fleischer; S B Goldberg; T H Browning; J N Cooper; E Friedman; F H Goldner; E B Keeffe; L E Smith
Journal:  JAMA       Date:  1989-01-27       Impact factor: 56.272

Review 9.  Occult blood screening for colorectal carcinoma: a critical review.

Authors:  J B Simon
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.